Karen Jung

Luteolin is a novel p90 ribosomal S6 kinase (RSK) inhibitor that suppresses Notch4 signaling by blocking the activation of Y-box binding protein-1 (YB-1)

Kristen M. Reipas, Jennifer Law, Nicole Couto et al. · Oncotarget · 2013 · 60 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +15

Identification of two novel phenotypically distinct breast cancer cell subsets based on Sox2 transcription activity

Fang Wu, Jingdong Zhang, Peng Wang et al. · Cellular Signalling · 2012 · 48 citations

Medicine, Cell Biology, Molecular Biology +11

DDX17 (P72), a Sox2 binding partner, promotes stem-like features conferred by Sox2 in a small cell population in estrogen receptor-positive breast cancer

Hind Alqahtani, Keshav Gopal, Nidhi Gupta et al. · Cellular Signalling · 2015 · 39 citations

Medicine, Cell Biology, Molecular Genetics +16

YB-1 regulates Sox2 to coordinately sustain stemness and tumorigenic properties in a phenotypically distinct subset of breast cancer cells

Karen Jung, Fang Wu, Peng Wang et al. · BMC Cancer · 2014 · 30 citations · Full text

Medicine, Molecular Biology, Oncology +16

β-Catenin, a Sox2 binding partner, regulates the DNA binding and transcriptional activity of Sox2 in breast cancer cells

Xiaoxia Ye, Fang Wu, Chengsheng Wu et al. · Cellular Signalling · 2013 · 30 citations

Life Sciences, Genetics, Molecular Biology +9